Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor ...

TruCytes Potency cell mimics offer a customizable, scalable, and efficient alternative to cell line target cells. This helps CAR-T developers accelerate assay validation and lot release, while ...

TruCytes Potency cell mimics offer a customizable, scalable, and efficient alternative to cell line target cells. This helps CAR-T developers accelerate assay validation and lot release ...

Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor. Cell and gene ...

"Preclinical findings illuminate the superior GSTP1 binding affinity and inhibitory potency of this novel prodrug ... improved specificity towards cancer cells relative to normal cells and with ...

This protein, called the chimeric antigen receptor or CAR, is what gives these engineered cells such potency against certain cancers and allows them to recognize and destroy malignant cells.